Advanced Small Intestine Cancer
1 clinical trials · Condition
◉ Watch Advanced Small Intestine Cancer
| Record | Firm | Date |
|---|---|---|
| NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal Cancers (NCT07060014) | The Methodist Hospital Research Institute | 2025-07-18 |
Track Advanced Small Intestine Cancer automatically
Every clearance here is in the API, with alerts when new ones post.